- 1. D-Mannitol
- [six-carbon sugar alcohol formed by reduction of mannose or fructose and widely distributed in plants and fungi. ( CSP )] (UMLS (NCI) C0024730) =Carbohydrate; Pharmacologic Substance ;
=sugar alcohol;
sweetening agent;
[IR100] IRRIGATION SOLUTIONS;
[CV709] DIURETICS, OTHER =MANNITOL HEXANITRATE;
AL OH 400MG/MG OH 400MG/SIMETHICONE 30MG TAB,CHEWABLE;
Aluminum Hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet;
Ascorbic Acid 300 MG / Ferrous fumarate 134 MG Chewable Tablet;
CAFFEINE 100 MG Oral (systemic) tablet;
Doxycycline 10 MG/ML Injectable Solution;
Menthol 0.0012 MG/MG / phenol 0.0072 MG/MG Lozenge;
Menthol 0.0012 MG/MG / phenol 0.0145 MG/MG Lozenge;
ULTRA-KLENZ,WOUND CLEANSER;
MANNITOL 100 MG/ML;
MANNITOL 150 MG/ML;
MANNITOL 200 MG/ML;
MANNITOL 250 MG/ML;
MANNITOL 0.54 GM/100ML;
MANNITOL 50 MG/ML;
MANNITOL 375 MG;
MANNITOL 400 MG;
MANNITOL 50 MG;
MANNITOL 10 MG;
MANNITOL 10 MG/ML;
MANNITOL 100 MG;
MANNITOL 200 MG;
MANNITOL 40;
MANNITOL 40 MG;
MANNITOL 5 %;
MANNITOL 5 MG;
MANNITOL 500 MG;
MANNITOL 61.3 MG/ML;
MANNITOL 75 MG;
MANNITOL 750 MG;
MANNITOL 80 MG;
MANNITOL 150 MG;
MANNITOL 1.5 GM/VIL | - 2. D1/3 MAGE3 HIS
- [A recombinant, chimeric protein derived from a melanoma antigenic epitope (MAGE-3) and recognized by specific cytotoxic T lymphocytes. MAGE-3, a human peptide epitope present in the cytosol of melanoma cells, may be expressed as the fusion protein D1/3-Mage-3; this fusion protein may boost antitumoral immune responses when used in a vaccine formulation. (NCI04) ( NCI )] (UMLS (NCI) C1327743) D1/3-MAGE-3 Fusion Protein;
D1/3-Mage-3-His Fusion Protein;
D1/3-Mage-3-His Fusion Protein (SB MAGE-3) =Amino Acid, Peptide, or Protein; Pharmacologic Substance |
home
